161 related articles for article (PubMed ID: 31055974)
1. Current treatment of lymphoma in pregnancy.
Gurevich-Shapiro A; Avivi I
Expert Rev Hematol; 2019 Jun; 12(6):449-459. PubMed ID: 31055974
[No Abstract] [Full Text] [Related]
2. Chemotherapy during Pregnancy: Cases of Hodgkin's and Non-Hodgkin's Lymphoma, Chronic Myeloid Leukemia, Breast Cancer, Nasopharyngeal Cancer, and Choriocarcinoma.
Beksac K; Orgul G; Ozyuncu O; Yurdakok M; Altundag K; Beksac MS
Oncol Res Treat; 2017; 40(7-8):441-445. PubMed ID: 28700986
[TBL] [Abstract][Full Text] [Related]
3. Novel agents for the treatment of lymphomas during pregnancy: A comprehensive literature review.
Luttwak E; Gurevich-Shapiro A; Azem F; Lishner M; Klieger C; Herishanu Y; Perry C; Avivi I
Blood Rev; 2021 Sep; 49():100831. PubMed ID: 33931297
[TBL] [Abstract][Full Text] [Related]
4. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
[TBL] [Abstract][Full Text] [Related]
5. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
6. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
Laport GF; Williams SF
Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600
[TBL] [Abstract][Full Text] [Related]
7. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
[TBL] [Abstract][Full Text] [Related]
8. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Specht L
Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
[TBL] [Abstract][Full Text] [Related]
9. Advances in chemotherapy for Hodgkin's and non-Hodgkin's lymphomas.
Semin Hematol; 1988 Apr; 25(2 Suppl 2):1-73. PubMed ID: 3399906
[No Abstract] [Full Text] [Related]
10. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
[TBL] [Abstract][Full Text] [Related]
11. Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
Bergeron C; Le Moine P; Le Prise-Fleury E; Jouan H; Tass P; Darcel F; Chatel M; Edan C; Patte C; Faivre J
Med Pediatr Oncol; 1993; 21(4):307-10. PubMed ID: 8469228
[TBL] [Abstract][Full Text] [Related]
12. [Lymphomas in adolescents: are childhood lymphoma therapy protocols suitable for this patient group?].
Bence Z; Kovács G; Jakab Z; Csóka M; Müller J
Magy Onkol; 2008 Dec; 52(4):357-62. PubMed ID: 19068463
[TBL] [Abstract][Full Text] [Related]
13. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
Delbeke D; Stroobants S; de Kerviler E; Gisselbrecht C; Meignan M; Conti PS
Oncologist; 2009; 14 Suppl 2():30-40. PubMed ID: 19819922
[TBL] [Abstract][Full Text] [Related]
14. Successful chemotherapy on a pregnant non-Hodgkin's lymphoma patient.
Toki H; Okabe K; Kamei H; Shimokawa T; Hiura M; Kondo M; Hirota Y
Acta Med Okayama; 1990 Dec; 44(6):321-3. PubMed ID: 2075830
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
16. Determining the sequence of novel therapies in the treatment of relapsed Hodgkin's lymphoma.
Narkhede M; Sarraf Yazdy M; Cheson B
Expert Rev Hematol; 2018 Oct; 11(10):773-780. PubMed ID: 30139285
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin's lymphoma and Hodgkin's disease: the Italian experience.
Zinzani PL
Ann Oncol; 2003; 14 Suppl 1():i43-5. PubMed ID: 12736231
[No Abstract] [Full Text] [Related]
18. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912.
Kobrinsky NL; Sposto R; Shah NR; Anderson JR; DeLaat C; Morse M; Warkentin P; Gilchrist GS; Cohen MD; Shina D; Meadows AT
J Clin Oncol; 2001 May; 19(9):2390-6. PubMed ID: 11331317
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Dodwell DJ; de Campos ES; Radford JA
Drugs; 1992 Jul; 44(1):1-8. PubMed ID: 1379906
[No Abstract] [Full Text] [Related]
20. Twin-track studies of ifosfamide and mitoxantrone (I-M) in recurrent high grade non-Hodgkin's lymphoma and Hodgkin's disease. Yorkshire Regional Lymphoma and Central Lymphoma Groups.
Child JA; Simmons AV; Barnard DL; Parapia L; Morgan M; Grace RJ; Fletcher J; Parker D; Norfolk DR; Stone J
Hematol Oncol; 1991; 9(4-5):235-44. PubMed ID: 1743626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
